After promoting CDH13 expression in K562-IMR cells, it inhabited the NF-κB signaling pathway and induced apoptosis in imatinib-resistant CML cells. The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.